Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years over the United States' insistence on confidential data.
This move came to light after a official document from December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesman later clarified that the US was seeking health data for research and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for further talks to secure a deal acceptable to both sides so the country's vital HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the security of Kenyans' health data.
After resuming office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral deals to boost openness and responsibility.
Based on reports, Sixteen African countries have to date agreed to similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.
"Effectively, our nation would supply the basic resources for medical research with no certainty that the resulting innovations would be available to our people should a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were undermining structures previously set up through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.
"This system is intended to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome ongoing dialogue with our US partners on how future co-operation might be arranged in a way that honours the independence and dignity of both nations."
Medical Community Reaction
Medical experts expressed it recognised the government's concerns, but suggested that talks should continue considering much of the country's HIV programmes depended on external financing.
"If technical issues arise, including those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group added.
This impasse underscores the complex challenges between accepting crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.